These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 21119363)
1. Expression and correlation of Lewis y antigen and integrins α5 and β1 in ovarian serous and mucinous carcinoma. Li Q; Liu S; Lin B; Yan L; Wang Y; Wang C; Zhang S Int J Gynecol Cancer; 2010 Dec; 20(9):1482-9. PubMed ID: 21119363 [TBL] [Abstract][Full Text] [Related]
2. Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma. Wang ST; Liu JJ; Wang CZ; Lin B; Hao YY; Wang YF; Gao S; Qi Y; Zhang SL; Iwamori M Oncol Rep; 2012 Apr; 27(4):1065-71. PubMed ID: 22138668 [TBL] [Abstract][Full Text] [Related]
3. Podocalyxin-like protein 1 expression and correlation with clinical characteristics in epithelial serous and mucinous ovarian carcinoma and tumor-like lesions. Ye F; Hu Y; Zhou C; Hu Y; Chen H Pathobiology; 2012; 79(6):307-13. PubMed ID: 22688257 [TBL] [Abstract][Full Text] [Related]
4. Cell proliferation activity unrelated to COX-2 expression in ovarian tumors. Yoshida A; Sarian LO; Andrade LA; Pignataro F; Pinto GA; Derchain SF Int J Gynecol Cancer; 2007; 17(3):607-14. PubMed ID: 17504375 [TBL] [Abstract][Full Text] [Related]
5. Alteration of BRCA-1 tumor suppressor gene expression in serous and mucinous ovarian neoplasms in the benign-borderline-malignant pathway. Yousif HMA; Mohammed RAA Curr Probl Cancer; 2019 Aug; 43(4):377-385. PubMed ID: 30446260 [TBL] [Abstract][Full Text] [Related]
6. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma. Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402 [TBL] [Abstract][Full Text] [Related]
7. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients. Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008 [TBL] [Abstract][Full Text] [Related]
8. FGF18 as a potential biomarker in serous and mucinous ovarian tumors. El-Gendi S; Abdelzaher E; Mostafa MF; Sheasha GA Tumour Biol; 2016 Mar; 37(3):3173-83. PubMed ID: 26427667 [TBL] [Abstract][Full Text] [Related]
9. [Expressions of osteopontin and B7-H4 in epithelial ovarian neoplasm and their significance]. Zhang LL; Shao SL; Wu Y Chin J Cancer; 2010 Jan; 29(1):25-9. PubMed ID: 20038306 [TBL] [Abstract][Full Text] [Related]
10. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression. Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014 [TBL] [Abstract][Full Text] [Related]
11. Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma. Yang G; He W; Cai M; Luo F; Kung H; Guan X; Zeng Y; Xie D Int J Gynecol Cancer; 2011 Apr; 21(3):486-93. PubMed ID: 21436696 [TBL] [Abstract][Full Text] [Related]
12. Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer. Samardzija C; Luwor RB; Quinn MA; Kannourakis G; Findlay JK; Ahmed N BMC Cancer; 2016 Jul; 16():432. PubMed ID: 27390927 [TBL] [Abstract][Full Text] [Related]
13. Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for P-cadherin targeted therapy: a retrospective cohort study. Kayahashi K; Mizumoto Y; Matsuoka A; Obata T; Iwadare J; Nakamura M; Daikoku T; Fujiwara H BMC Cancer; 2021 Jan; 21(1):32. PubMed ID: 33413178 [TBL] [Abstract][Full Text] [Related]
14. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors]. Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848 [TBL] [Abstract][Full Text] [Related]
15. Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance. Gao J; Hu Z; Liu J; Liu D; Wang Y; Cai M; Zhang D; Tan M; Lin B Med Oncol; 2014 May; 31(5):920. PubMed ID: 24692145 [TBL] [Abstract][Full Text] [Related]
16. MDM2 Expression in Serous and Mucinous Epithelial Tumours of the Ovary. Abdelaal SE; Habib FM; El Din AA; Gabal SM; Hassan NS; Ibrahim NA Asian Pac J Cancer Prev; 2016; 17(7):3295-300. PubMed ID: 27509966 [TBL] [Abstract][Full Text] [Related]
17. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours. Saied EM; El-Etreby NM Ann Diagn Pathol; 2017 Apr; 27():62-68. PubMed ID: 28325363 [TBL] [Abstract][Full Text] [Related]
18. Pattern of HER-2 Gene Amplification and Protein Expression in Benign, Borderline, and Malignant Ovarian Serous and Mucinous Neoplasms. Mohammed RAA; Makboul R; Elsers DAH; Elsaba TMAM; Thalab AMAB; Shaaban OM Int J Gynecol Pathol; 2017 Jan; 36(1):50-57. PubMed ID: 27309616 [TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas]. Shao HL; Shen DH; Xue WC; Li Y; Yu YZ Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760 [TBL] [Abstract][Full Text] [Related]
20. Early stage primary ovarian mucinous carcinoma: Outcome-based clinicopathological study in comparison with serous carcinoma. Tian Q; Lu B; Ye J; Lu W; Xie X; Wang X J Int Med Res; 2016 Apr; 44(2):357-66. PubMed ID: 26880793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]